Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer

PURPOSE: The aim of this study was to compare fluorodeoxyglucose positron emission tomography (FDG PET/CT) and contrast-enhanced computed tomography (CE-CT) for the prediction of progression-free survival (PFS) and disease-specific survival (DSS) in patients with stage IV breast cancer undergoing sy...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Eur J Nucl Med Mol Imaging
Hoofdauteurs: Riedl, Christopher C, Pinker, Katja, Ulaner, Gary A, Ong, Leo, Baltzer, Pascal, Jochelson, Maxine S, McArthur, Heather, Gönen, Mithat, Dickler, Maura, Weber, Wolfgang A
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2017
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5526620/
https://ncbi.nlm.nih.gov/pubmed/28462446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3703-7
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items